Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-30

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Accord Healthcare's methylphenidate hydrochloride under an ANDA, adjusting the regulatory status of this generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)